Antiretroviral news.

The 12th World AIDS Conference in Geneva explored issues associated with the use of antiretrovirals and resistance. Areas examined included resistance to new antiretroviral agents, the use of Hydroxyurea as a standard therapy, novel dosing strategies, new antiretroviral agents, and dual protease inhibitor therapy. Major conference themes involving antiretroviral resistance examined resistance profiles of new antiretroviral agents, cross-resistance within and across drug classes, the use of genotype and phenotype analysis, and the transmission of multi-drug resistant virus. While information on salvage therapy remains disappointing, it is noted that several ongoing trials are continuing to address the issue.